Pneumoconiosis
11
4
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis
Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients
Pneumoconiosis and Dust Exposure China Cohort
FAPI PET for Lung Fibrosis
Acceptance-based Healthy Lifestyles Program for Patients With Pneumoconiosis
Potential of Deep Learning in Assessing Pneumoconiosis Depicted on Digital Chest Radiography
Evaluation of Pneumoconiosis High Risk Early Warning Models
The Experience of Patients and Family Caregivers in Managing Pneumoconiosis in the Family Context
A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells
Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis
Specialized Center of Research in Occupational and Immunologic Lung Disease